Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.
Xiao F, Pu J, Wen Q, Huang Q, Zhang Q, Huang B, Huang S, Lan A, Zhang Y, Li J, Zhao D, Shen J, Wu H, He Y, Li H, Yang X.
Xiao F, et al.
Oncotarget. 2017 Jul 18;8(29):48488-48506. doi: 10.18632/oncotarget.17290.
Oncotarget. 2017.
PMID: 28489582
Free PMC article.
Review.